Vanda Pharmaceuticals, Inc. (VNDA)

8.17 +0.02 (+0.25%) USD  |  NASDAQ  |  Feb 24, 16:00
8.36 +0.19 (+2.33%) Pre-Market: 08:17
More

Vanda Pharmaceuticals Net Income (Quarterly)

Net Income (Quarterly) Chart

View Net Income (Quarterly) for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Axsome Therapeutics, Inc. Upgrade
AnaptysBio, Inc. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade
Protagenic Therapeutics, Inc. Upgrade